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ABSTRACT
Pancreatic cancer, known for its rapid progression and poor prognosis, usually presents with obstructive 
jaundice. Biliary drainage can be achieved by various techniques and approaches, with endoscopic drainage as 
the preferred method. However, open drainage of the biliary tree is indicated when unresectable tumor is found 
during resection surgery. This is a case of biliary drainage with a double bypass biliodigestive construction, 
which could be performed in patients with unresectable cancer in the head of the pancreas presenting with 
obstructive jaundice and gastric outlet obstruction.
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ABSTRAK
Kanker pankreas adalah kanker yang perkembangannya cepat dan prognosisnya buruk, biasanya muncul 
disertai ikterus obstruktif. Drainase bilier dapat dicapai dengan berbagai teknik dan pendekatan, satu di 
antaranya dengan drainase endoskopi sebagai metode yang lebih sering dilakukan. Namun, drainase terbuka dari 
saluran bilier merupakan indikasi apabila tumor yang ditemukan selama operasi reseksi, tidak dapat dibedah. 
Laporan kasus ini adalah kasus drainase bilier dengan konstruksi biliodigestif bypass ganda pada pasien dengan 
kanker caput pankreas yang tidak dapat dioperasi, yang mengalami ikterus obstruktif dan obstruksi lambung.
Kata kunci: kanker pankreas, drainase bilier, operasi paliatif
INTRODUCTION
Obstructive jaundice is a common symptom in 
patients with the periampullary cancer (cancer located 
near the ampulla of vater) or cancer in the head of the 
pancreas. Surgical resection is the only curative method 
available. Pancreas adenocarcinoma maintain its 
reputation as one of the most lethal of gastrointestinal 
cancers.1,2 Unresectable pancreatic cancer, particularly, 
progresses rapidly and therefore has poor prognosis. 
Several palliative approaches for biliary drainage can 
be used for these cancers presenting with obstructive 
jaundice. These approaches include endoscopic biliary 
stent placement, percutaneous transhepatic biliary 
drainage, bypass surgery and chemotherapy.3 
Approximately 5-20% patients with pancreatic 
FDQFHUKDYHLQ¿OWUDWLYHWXPRUH[SDQVLRQZKLFKFDXVHV
gastric outlet or pyloroduodenal obstruction.4 A large 
portion of these patients are not eligible for surgical 
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resection. Despite intensive research and therapeutic 
achievements in recent decades, the prognosis of 
pancreatic cancer has not significantly improved. 
The mean life expectancy for patients at all stages 
remains six to eight months due to local progress of 
disease, lymphatic metastases, perineural invasion, 
or disseminated metastases at the time of diagnosis.4
We hereby describe a case of a man with obstructive 
jaundice caused by unresectable pancreatic cancer 
in the head of the pancreas. Open bilio-digestive 
bypass was performed with cholecystojejunostomy, 
gastrojejunostomy, and jejunojejunostomy. This case 
showed that palliative surgery for only biliary drainage 
is the only option for advanced end stage pancreatic 
cancer. 
CASE ILLUSTRATION 
A 57 year old male presented with a 7 month history 
of epigastric pain. In addition, he had jaundice for 3 
months, accompanied by dark colored urine, loss of 
appetite, pruritus as well as nausea and occasional 
vomiting. He had been admitted to another hospital 
3 days before, where the diagnosis of obstructive 
MDXQGLFHZDV¿UVWHVWDEOLVKHG3K\VLFDOH[DPLQDWLRQ
showed that the patient looked moderately to severely 
ill. He was alert with normal hemodynamic, and 
slight tachypnea with respiratory rate of 24x/minute. 
He was icteric with palpable liver and elicited right 
hypochondria and epigastric pain.
Results from the other hospital showed anemia, 
leukocytosis, elevated transaminase (AST 111 U/L, 
ALT 99 U/L), and bilirubin level (total bilirubin 7.63 
mg/dL, direct bilirubin 5.23 mg/dL). Serology for 
hepatitis B and C were not reactive. Urinalysis showed 
positive for bilirubin and urobilinogen. Abdominal 
ultrasound revealed intra hepatic bile duct (IHBD) and 
extra hepatic bile duct (EHBD) dilatation, but pancreas 
could not be visualized, due to bowel gas. Non-contrast 
CT scan of the upper abdomen revealed intrahepatic 
and extrahepatic duct dilatation due to a mass.
 Upon admission, there was a slight raise of 
transaminase and bilirubin level, with marked elevated 
Gamma GT and ALP level, strongly suggestive of an 
obstructive jaundice. There were normal amylase and 
lipase level, 29.0 U/L ( N: < 220 U/L), 17.00 U/L (N: 
< 60 U/L) respectively and no PT prolongation noted. 
Raised tumor marker checked were AFP (> 2000.00 
ng/mL) and CA 19-9 (290.05 U/mL). Abdominal CT 
scan with contrast done on the 3rd day of admission 
VKRZHGQRQIRFDOQRQLQ¿OWUDWLYHKHSDWRPHJDO\DQG
tumor in the head of pancreas which caused dilatation 
of CBD and IHBD. 
Figure 1. Abdominal CT scan showed pancreatic cancer
The patient was given oral and parenteral nutrition 
XVLQJ&RPELÀH[® and Ivelip® infusion, antimicrobials 
consisting Ceftazidime 1gr t.i.d and metronidazole 
500mg b.i.d , omeprazole, paracetamol, and ketorolac. 
Transfusion of pack red cells and infusion of albumin 
were given to the patient. Hb was increased to 11.9 g/
dL and there were raised leucocyte count. Open biliary 
drainage was performed on the 20th day of admission. 
Surgical finding showed pancreatic tumor in the 
head of the pancreas with a diameter of more than 
5 cm, nodules in the liver with ascites and duodenal 
obstruction. Double bypass biliodigestive construction 
was performed, consisted of cholecystojejunostomy, 
gastrojejunostomy and jejunojenjunostomy. Cytology 
RIWKHDVFLWLFÀXLGUHYHDOHGWKHSUHVHQFHRIPDOLJQDQW
cells consistent with adenocarcinoma.
DISCUSSION
Despite advances in chemotherapy regimens and 
improvement in radiation delivery, pancreatic cancer 
remains to be associated with a grim prognosis. 
Overall, the lifetime risk of pancreatic cancer is 1 in 67 
individuals, with an expected incidence of 48,960 new 
cases for pancreatic cancer (24,840 men and 24,120 
women) and expected 40,560 deaths from pancreatic 
cancer (20,710 men and 19,850 women) in the United 
States. Although, pancreatic cancer will account for 
only 3% of all cancers diagnosed in the United States, 
it will be the cause of 7% of cancer deaths and is the 
4th most common cause of cancer-related deaths after 
more common malignancies such as breast, colorectal, 
prostate and lung cancers.5,6
3DQFUHDWLFFDQFHULVRIWHQGLI¿FXOWWRGLDJQRVHLQ
WKHHDUO\VWDJHV7KLVLVEHFDXVHWKHUHDUHQRVSHFL¿F
cost effective screening tests for people with pancreatic 
cancer who have no symptoms. The opportunity to 
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detect pancreatic cancer, while it remains curable, 
depends on the ability to identify and screen high-
risk populations before their symptoms arise. Early 
symptoms of pancreatic cancer result from a mass 
effect. Common presenting symptoms of pancreatic 
cancers include jaundice, pain, weight loss, and 
steatorrhoea.7
The majority of patients with pancreatic cancer 
progress to either metastatic or locally advanced disease 
LQ WKH DV\PSWRPDWLF SKDVH'H¿QLQJ WKH WUHDWPHQW
strategy requires a specialized multidisciplinary 
team that includes surgeons, medical oncologists, 
gastroentero-hepatologist, radiologists, and supportive 
and palliative care specialists.7 In this case, the 
pancreatic head cancer presented as a non resectable 
tumor with metastases, therefore positioning this 
cancer in an advanced stage. The tumor spread into 
the duodenum, resulting duodenal obstruction, which 
were found during surgery. 
An increase in serum CA 19-9 is seen in almost 80% 
of the patients with advanced disease. The level of CA 
19-9 is correlated to the level of bilirubin and any cause 
of cholestasis is able to induce false-positive results. 
Although it is not useful for the primary diagnosis 
RISDQFUHDWLFFDQFHU&$KDVDVLJQL¿FDQWYDOXH
as a prognostic factor and can be used as a marker 
to measure disease burden and potentially guide 
treatment decisions. A preoperative serum CA 19-9 
OHYHO8,P/FOHDUO\LQGLFDWHVDZRUVHSURJQRVLV
after surgery.7 
In this case, CA 19-9 level was 290.05 UI/mL. 
Alfa feto protein was also increased to a level of 
more than 2000.00 ng/mL (normal: < 5 ng/mL). 
Aside from that, measurement of bilirubin in blood 
can be helpful in determining the cause of jaundice. 
Marked elevation of liver test (AST and ALT) suggests 
LQÀDPPDWLRQRI WKHOLYHU(OHYDWLRQRI WKH$/3DQG
GGT suggests disease or obstruction of the bile duct. 
In this case hemoglobin became decreased, with 
hypoalbuminemia, leucocytosis, elevation of ALT, 
AST, ALP and GGT. Viral marker were non-reactive. 
Both abdominal ultrasound and non-contrast CT scan 
showed dilatation of IHBD and CBD. CT scan with 
contrast of upper abdomen showed a tumor in the head 
of pancreas causing pressure on CBD with dilatation 
of IHBD and CBD. 
Preoperative biliary drainage performed for 
resectable pancreatic cancers with obstructive 
jaundice is intended to improve the post-operative 
outcome.1,8 The three commonly used methods for 
achieving preoperative biliary drainage includes 
endoscopic retrograde biliary stent placement 
(ERBS), endoscopic nasobiliary drainage (ENBD) 
and percutaneous transhepatic biliary drainage.9 The 
endoscopic positioning of a biliary endoprosthesis has 
become a relatively easy procedure for experienced 
endoscopists. Late cholangitis occurred only in case 
of dislodgement or clogging of the endoprosthesis. 
Many of the late complications related to biliary 
endoprostheses are due to clogging. Huang et al 
found that PTBD can improve surgical outcomes by 
reducing severe complication rate in jaundice patients 
following pancreaticoduodenectomy.9 In this case, 
open bilio-digestive bypass was performed instead 
of preoperative biliary drainage. Whipple procedure 
(pancreaticoduodenectomy) was not performed, 
because the tumor size was more than 3 cm and there 
were metastases to the liver and peritoneum. 
The pancreatic cancer in this case was developed 
rapidly. During 17 days of hospitalization, the disease 
progressed into causing duodenal obstruction and 
developing ascites that revealed metastases. Common 
manifestations of end stage pancreatic cancer include 
gastric outlet obstruction due to tumor ingrowth to 
the duodenum, cahexia, deep venous thrombosis 
(Trousseau’ phenomenon), anasarca and ascites. 
Ascites is formed in only 20% of pancreatic cancer 
and its cause is multifactorial. It can occur due to 
obstruction of diaphragmatic lymphatics, increased 
production of exudates by the tumor itself and the 
production of osmotically active peptides that alter 
vascular permeability to favor ascites formation. The 
mortality of patients with those common manifestation 
is high before completing a standard course of 
therapy.10,11 
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